Daily THC Causes Inflammation in Adolescent Brain Amygdala — CBD Prevents It

What the researchers found

THC induced GFAP and complement factor-B upregulation (proinflammatory gliosis) exclusively in the adolescent amygdala, not in other brain regions or adults. THC also reduced synaptic plasticity markers (stathmin-1, NrCAM). CBD co-treatment prevented astrogliosis but did not restore synaptic plasticity markers. The vulnerability was traced to astrocyte-localized CB1R expression specifically in the amygdala.

Why it matters

This study provides a molecular mechanism for why adolescent cannabis use increases risk of anxiety and neuropsychiatric disorders: THC specifically inflames the adolescent amygdala (the brain region governing fear and emotion). The CBD protective effect is clinically significant.

The numbers in context

Adolescent-specific GFAP and complement factor-B upregulation in amygdala. CB1R expression: astrocyte-localized in amygdala, neuronal in cortex and striatum. CBD prevented gliosis but not synaptic plasticity loss. Astrogliosis correlated with fragmented sleep; reduced plasticity correlated with anxiety.

How the study worked

Multi-species study: proteomic analysis of amygdala from adolescent squirrel monkeys chronically treated with THC, validated in adolescent (P35) and adult (P70) rats. Behavioral testing, primary astrocyte cultures for mechanistic studies. CB1 knockout cells used as controls.

What this study cannot tell us

Animal models (primate and rat) may not fully recapitulate human adolescent brain development. CBD prevented inflammation but not all THC-induced changes. Chronic dosing regimen may not match typical human use patterns.

How to read the evidence

Strong preclinical design with two species, CB1 knockout controls, and behavioral correlation, but animal-to-human translation uncertain.

When this study was published

2025 publication.

The bigger picture

The finding that CBD can prevent THC-induced brain inflammation in adolescents has important implications for harm reduction. As cannabis products increasingly contain high THC with minimal CBD, adolescent users may be at greater risk than those using balanced products.

Questions still open

• Would balanced THC:CBD cannabis products be safer for adolescent brain development?
• Is the amygdala inflammation reversible after THC cessation?

Common questions

Read the original research

Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment.

Biological psychiatry global open science, 5(4), 100496

Citation

Sun, Yalin; Sivasubramanian, Meenalochani; Milenkovic, Marija; Gumbert, Andrew; Bergman, Jack; Ge, Preston; Heiman, Myriam; Di Raddo, Marie-Eve; Withey, Sarah L; Madras, Bertha K; George, Susan R. (2025). Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment.. Biological psychiatry global open science, 5(4), 100496. https://doi.org/10.1016/j.bpsgos.2025.100496

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk